References
- Amighi K., Timmermans J., Puigdevall J., Bakes E., Moës A. J. Drug Dev. Ind. Pharm. 1998; 24(6)509–515
- Kelly K. A. Physiology of the Gastrointestinal Tract, L. R. Johnson. Raven Press, New York 1981; 393–410
- Porter S. C. Multiparticulate oral drug delivery. Drugs and Pharmaceutical Science, I. Ghebre-Sellassie. Marcel Dekker Inc., New York 1994; Vol. 65: 217–284
- Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A. J. Pharm. Sci. 1982; 71: 1169–1172
- Aoyagi N., Ogata H., Kaniwa N., Uchiyama M., Yasuda Y., Tanioka Y. J. Pharm. Sci. 1992; 81: 1170–1174
- Dressman J. B. Pharm. Res. 1986; 3: 123–131
- Vandewalle M., Fagoo M., Baltes E., Brouwers L. 1990, UCB Internal Report No. LE90A221
- American College of Clinical Pharmacy. J. Clin. Pharmacol. 1982, suppl. 22: S1–S23
- Schuirman D. J. J. Pharmacokin. Biopharm. 1987; 715: 657–680
- E. C. Investigation of bioavailability and bioequivalence. 1989; 159–161, Rules governing medicinal products in the European Community, III
- Steinijans V. W., Hauschke D. Int. J. Clin. Pharmacol. Therap. Toxicol. 1990; 28(3)105–110
- Lui C. Y., Amidon L., Berardi R. R., Fleisher D., Youngberg D., Dressman J. B. J. Pharm. Sci. 1986; 75: 271–274